Every earnings call for HCG — management tone, guidance, KPIs and promise tracking, quarter by quarter.
HCG · 5 transcripts · Healthcare · latest Q4 FY26Healthcare Global Enterprises Limited has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
FY26 Revenue ₹2,545 cr (+15% YoY); FY26 Adjusted EBITDA ₹471 cr (+19% YoY); FY26 Adjusted EBITDA Margin 18.5%. FY26 Revenue grew 15% YoY to ₹2,545 crores.
Read full transcript & analysisRevenue ₹633 cr (+13% YoY); Adjusted EBITDA ₹111 cr (+20% YoY); EBITDA Margin 17.5%. Revenue grew 13.4% YoY to INR 633 crore in Q3 FY26.
Read full transcript & analysisAdjusted EBITDA FY25 ₹396 cr (+17% YoY); Adjusted EBITDA Margin FY25 17.8%; PAT FY25 ₹44 cr. Revenue (ex-Milann) grew 20% in Q4 FY25 to INR571.1 crores.
Read full transcript & analysisRevenue ₹2,200 cr; EBITDA ₹396 cr. Revenue of ₹2,200 crores in FY2025, growing at a 15% CAGR (FY20-25).
Read full transcript & analysisRevenue ₹559 cr (+19% YoY); Adjusted EBITDA ₹92 cr (+15% YoY); Adjusted EBITDA Margin 16.5%. Revenue of INR 559 crores, up 19% YoY.
Read full transcript & analysis